BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/31/2024 8:51:01 AM | Browse: 224 | Download: 12
Publication Name World Journal of Clinical Cases
Manuscript ID 97881
Country Egypt
Category Pharmacology & Pharmacy
Manuscript Type Editorial
Article Title Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression
Manuscript Source Invited Manuscript
All Author List Basma M E Mohamed and Mohamed E A Abdelrahim
Funding Agency and Grant Number
Corresponding Author Mohamed E A Abdelrahim, PhD, Professor, Department of Clinical Pharmacy, Faculty of pharmacy, Beni-suef University, Beni suef 23343, Egypt. mohamed.abdelrahim@pharm.bsu.edu.eg
Key Words Idiopathic pulmonary fibrosis; Pirfenidone; Pirfenidone anti-inflammatory mechanism; Pirfenidone anti-fibrotic activity
Core Tip Pirfenidone is commonly used to treat idiopathic pulmonary fibrosis (IPF) in its early stages, but it has also demonstrated a notable impact on the disease in its advanced stages. In individuals with IPF who had substantial deterioration of their lung function, pirfenidone had a similar degree of efficacy. Pirfenidone appears to be safe when given to patients with advanced IPF, and it has a favorable benefit-risk profile, making it an appropriate treatment option for patients with idiopathic pulmonary fibrosis.
Citation <p>Mohamed BME, Abdelrahim MEA. Timing impact on the initiation of pirfenidone therapy on idiopathic pulmonary fibrosis disease progression. <i>World J Clin Cases</i> 2024; 12(32): 6538-6542</p>
Received
2024-06-11 14:29
Peer-Review Started
2024-06-11 14:29
To Make the First Decision
Return for Revision
2024-07-25 02:24
Revised
2024-07-25 20:28
Second Decision
2024-07-31 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-07-31 08:51
Articles in Press
2024-07-31 08:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
2024-08-13 02:17
Typeset the Manuscript
2024-08-22 14:11
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com